HEALTHCARE techniques around the globe are grappling with the arrival of a brand new sort of weight-loss therapy: injections primarily based on the medication semaglutide, which is branded as Wegovy or Ozempic.
The UK is among the many first international locations the place semaglutide appears set to be made out there for weight-loss therapy by way of a publicly funded well being system. Unfortunately, many docs suppose England’s steerage physique has made a misstep by recommending individuals be restricted to 2 years of use, despite the fact that the drug is supposed to be taken long-term. Health techniques in different international locations are additionally debating how to answer this unprecedented state of affairs, …
Source: www.newscientist.com